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A heavy water (2H2O) labeling method recently developed to measure cell proliferation in vivo is applied here to the
measurement of murine epidermal cell turnover and to investigate conditions in which keratinocyte proliferation is
either inhibited or stimulated. The technique is based on incorporation of 2H2O into the deoxyribose moiety of
deoxyribonucleotides in dividing cells. Label incorporation and die-away studies in cells isolated from C57BL/6J
mouse epidermis revealed the replacement rate to be 34%–44% per wk (half-life of 1.6–2 wk). The kinetics provided
evidence of a non-proliferative subpopulation of cells (10%–15% of the total) within the epidermis. Topical ad-
ministration of 7,12-dimethylbenz(a)anthracene and 12-O-tetradecanoylphorbol-13-acetate for 3 wk increased ep-
idermal cell proliferation by 55% in SENCAR mice. Topical addition of lunasin, an anti-mitotic agent from soy,
decreased epidermal cell proliferation modestly though significantly (16% given alone, 9% given with carcinogens).
Caloric restriction (by 33% of energy intake) for 4 wk decreased the epidermal cell proliferation rate by 45% in
C57BL/6J mice. In summary, epidermal cell proliferation can be measured in vivo using 2H2O labeling in normal,
hyper- and hypo-proliferative conditions. Potential applications of this inherently safe method in humans might
include studies of psoriasis, wound healing, chemopreventive agents, and caloric intake.
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The kinetics of skin cell turnover are of interest for a variety
of physiologic and pathologic conditions, including skin
cancer, wound healing, and psoriasis (Weinstein et al, 1985).
The skin is a continuously self-renewing organ, with a com-
plex, multilayered kinetic organization. The epidermis con-
tains mainly keratinocytes, along with a minor population of
dendritic cells, stem cells, and possibly a pool of quiescent
cells (Dover, 1993; Haake et al, 2001). Keratinocytes orig-
inate in the basal layer of the epidermis, through division of
a population of stem cells. The daughter cells then divide
several times as transit amplifying cells, which lose prolif-
erative capacity and differentiate into post-mitotic, keratin-
rich cells as they migrate upward to the spinous layer of the
epidermis. As these cells continue their transit through the
granular layer, they become anucleate and form the upper-
most, cornified layers which ultimately are sloughed off
(Dover, 1993; Haake et al, 2001). Turnover of the epidermis
allows the organ to maintain its barrier function, repair in-
jured skin in wound healing, and respond to stimuli that
promote or inhibit cell proliferation.
The kinetics of cells, keratin, and lipids in the skin could
provide useful information about skin biology in health and
disease. Previous studies, however, have yielded inconsist-
ent measurements of epidermal kinetics (Dover, 1993; Fair-
ley and Zivony, 2001). Estimates of epidermal cell transit
time have ranged from 5 to 11 d in mouse dorsum (Downes
et al, 1967; Potten, 1975; Jensen and Esterly, 1977) and
from 12 to 48 d in human skin (Epstein and Maibach, 1965;
Weinstein and Van Scott, 1965; Halprin, 1972; Plewig and
Braun-Falco, 1975). Reported human epidermal cell turno-
ver times have ranged from 154 to 641 h (Epstein and Mai-
bach, 1965; Christophers and Schaumloffel, 1967) to 71 d
(Halprin, 1972). It has also been noted (Clausen et al, 1983)
that some keratinocytes in S-phase do not incorporate
labeled deoxyribonucleoside precursors, which could
complicate interpretation of labeling experiments with 3H-
thymidine (3HdT) or bromodeoxyuridine (BrdU). Differences
among animal models, sites of skin sampled, and method-
ologies could therefore have contributed to variations in
kinetic measurements of epidermal cells. A reliable and
reproducible measure of keratinocyte proliferation would
be useful for understanding many aspects of normal skin
biology.
There are also uncertainties regarding the extent of ker-
atinocyte turnover in various skin diseases. Hyper-prolifer-
ation may represent a risk factor for skin cancer and occurs
in physiologic conditions, such as wound healing and
altered permeability barrier function (Proksch et al, 1991),
as well as pathological conditions, such as psoriasis
(Weinstein and Van Scott, 1965; Weinstein et al, 1985). The
effects of chemopreventive or anti-psoriatic agents on
keratinocyte proliferation, for example, would be of interest
to measure if an appropriate assay were available.
Abbreviations: VAL, ad libitum; CR, caloric restriction; DMBA, 7,
12-dimethylbenz(a)anthracene; GC/MS, gas chromatography/
mass spectrometry; 3HdT, 3H-thymidine; 2H2O, heavy water; TPA,
12-O-tetradecanoylphorbol-13-acetate
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We have recently developed a method for measuring cell
proliferation in vivo using stable isotope labeling and mass
spectrometric analysis (Fig 1a) (Neese et al, 2001, 2002).
This technique is based on endogenous labeling of DNA in
dividing cells through the de novo nucleotide synthesis
pathway, the contribution of which is relatively constant and
unaffected by availability of extracellular deoxyribonucleo-
sides or by label reincorporation (Neese et al, 2001, 2002).
Other technical advantages of this approach have been
described elsewhere (Neese et al, 2001, 2002). A particu-
larly convenient approach is to label with heavy water
(2H2O), which allows long-term labeling studies at constant
precursor pool enrichments by administration of 2H2O in
drinking water (Neese et al, 2002; Collins et al, 2003; Kim
et al, 2004). After 2H2O administration, the cells of the
tissue of interest are isolated, the DNA is extracted, and
a derivative of the deoxyribose moiety of purine de-
oxyribonucleosides is analyzed for 2H enrichment by gas
chromatography/mass spectrometry (GC/MS). A tissue that
is nearly fully replaced, such as bone marrow or blood
monocytes, is then used as a reference value for the cal-
culation of fractional replacement of cells in the tissue of
interest. This approach has been successfully applied to
measure turnover of T cells, adipocytes, colonocytes, leu-
kemic cells, mammary epithelial cells, and other cells (Mac-
allan et al, 1998; Chu et al, 1999; Hellerstein et al, 1999;
Antelo et al, 2000; Kim et al, 2000; McCune et al, 2000;
Misell et al, 2000; Mohri et al, 2000; Schwartz et al, 2003;
Strawford et al, 2004; Kim et al, 2004, in press). Stable iso-
tope labeling is safe for use in humans and yields highly
reproducible, quantitative measurements (Neese et al, 2001,
2002). Here, we demonstrate the feasibility of this method
for the study of epidermal cell turnover, including investi-
gation of conditions in which epidermal cell proliferation is
either inhibited or stimulated in appropriate animal models.
Results
Stable isotope incorporation and decay studies demon-
strate turnover time for normal murine epidermal
cells In normal C57BL/6J mice, continuous labeling with
2H2O revealed the replacement or turnover rate of murine
epidermal cells to be 34% per wk, or a half-life of 2 wk (Fig
2a). Plateau values for fractional replacement were attained
after 5 wk of 2H2O administration. The calculated percent-
age of new cells reached at plateau was 85%–90%, indi-
cating that 10%–15% of the cells within the epidermis did
not proliferate during the 6 wk of labeling. Fig 2b confirms
that the expected level of 2H2O in body water was achieved
and was stable in the mice (approximately 2.5%–3.0%).
These results establish that a 2-wk labeling period with 4%
2H2O in drinking water represents an effective protocol for
measuring keratinocyte kinetics and that the replacement
rate of normal murine epidermal cells is 34% per wk.
Whole skin proliferation was also measured in mice given
2H2O. Whole skin, which includes dermis as well as epi-
dermis, gave about 50% lower proliferation rates than ep-
idermis alone (24.0% versus 48.8% new cells after 2 wk),
indicating that cells in the dermis (primarily fibroblasts) pro-
liferate at a lower rate than epidermal keratinocytes, and
that these layers need to be separated to allow accurate
measurement of epidermal cell kinetics.
Label decay (dilution) kinetics in epidermal cells from
normal C57BL/6J mice indicated a turnover rate of 44% per
wk (half-life of 1.6 wk) (Fig 2c). These results are similar to
the label incorporation results (Fig 2a). Enrichment of DNA in
epidermal cells declined rapidly during the first 4 wk of label
die-away, but a low level of isotopic labeling persisted 11
wk after discontinuing 2H2O intake (Fig 2c). The latter finding
suggests that there is a pool of slowly cycling, label-retain-
ing cells in epidermis––that is, two pools of epidermal cells
are present with distinct kinetics, as has been shown pre-
viously with stable isotope labeling for T cells (Hellerstein
et al, 2003), bone marrow precursor cells (Schwartz et al,
2000, 2003), and colon epithelial cells (Kim et al, 2004).
Body water 2H2O enrichments were negligible 1 wk after
discontinuing 2H2O intake (not shown), so low-level incor-
poration of label into newly replicated DNA cannot explain
the label retention observed in epidermal cells.
Carcinogens (7,12-dimethylbenz(a)anthracene (DMBA)
and 12-O-tetradecanoylphorbol-13-acetate (TPA)) in-
crease epidermal cell proliferation Next, we asked
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Figure 1
Overview of stable isotope incorporation and experimental design
of lunasin and carcinogen applications. (a) Schematic illustrates
pathways for labeling DNA in dividing cells. Abbreviations: G, glucose;
PRPP, phosphoribosyl pyrophosphato; GNG, gluconeogenesis; P,
phosphate; R, ribose; DNPS, de novo purine synthesis pathway;
DNNS, de novo nucleotide synthesis pathway; NDP, nucleoside di-
phosphate; RR, ribonucleoside reductase; dNTP, deoxyribonucleoside
triphosphate; dN, deoxyribonucleosides; dT, thymidine deoxyribonuc-
leoside; BrdU, bromodeoxyuridine. (b) Lunasin (or vehicle) was applied
topically to SENCAR mice twice a week for 4 wk. Topical carcinogen
treatment began 1 wk later, involving one DMBA (or vehicle) application
and subsequent twice weekly TPA (or vehicle) applications. 2H2O label
was administered during the last 2 wk of the study. Mice were eu-
thanized after 4 wk of study.
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whether putative stimulators and inhibitors of epidermal cell
proliferation resulted in detectable changes in epidermal
cell kinetics as measured by the 2H2O technique. SENCAR
mice were given 2H2O for 2 wk (this timing based on the
results from the label incorporation studies in normal mice)
and were given topical carcinogen applications. DMBA and
TPA application for 3 wk resulted in 55% higher fractional
epidermal cell proliferation rates compared with vehicle-
treated mice (Fig 3a, po0.05). Interestingly, the fractional
replacement of the epidermal cells in carcinogen-treated
mice approached 100%, which suggests that non-prolifer-
ative or slowly cycling cell populations in epidermis were
also activated by the treatment with DMBA and TPA.
Lunasin reduces epidermal cell proliferation The effect
of topical administration of the anti-mitotic agent lunasin,
derived from soybean (Galvez and de Lumen, 1999; Galvez
et al, 2001), was also tested in SENCAR mice. We com-
pared SENCAR mice with vehicle treatment (N), topical
lunasin treatment alone (L), carcinogen treatment alone (C),
or lunasin plus carcinogen treatment (CL) (n¼ 6 per group).
With lunasin applications at 0.625 mg per mL to 3 cm2 twice
weekly for 4 wk, the L group exhibited a statistically sig-
nificant 16% decrease in epidermal cell proliferation com-
pared with the N group (Fig 3a). CL mice also exhibited a
small but significant 9% decrease in epidermal cell prolif-
eration rate compared with the C group (Fig 3a). These re-
sults show that 4 wk of lunasin treatment exerted a modest
but significant anti-proliferative effect on keratinocytes
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Figure 2
Fractional replacement of epidermal cells and body water enrich-
ment during label incorporation study and excess enrichment of
epidermal cells during label decay study. (a) For the label incorpo-
ration study, C57BL/6J mice were given continuous 2H2O label for var-
ying durations up to 6 wk. Fractional replacement (f) was determined by
GC/MS analysis of excess 2H enrichment in the deoxyribose moiety of
purine deoxyribonucleosides from DNA of epidermal cells, divided by
that of bone marrow cells. (b) Body water content of 2H2O was deter-
mined by GC/MS analysis from blood collected by cardiac puncture. (c)
In the label decay study, 2H2O was administered to C57BL/6J mice for
4 wk and discontinued for varying durations up to 11 wk. Excess 2H
enrichment (EM1) was determined by GC/MS analysis of epidermal cell
DNA. Data are mean  SD (n¼ 3 per time point).
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Figure3
Fractional replacement of epidermal cells in mice treated with
topical carcinogens and lunasin and in calorically restricted mice
as compared with ad libitum (AL) fed mice. (a) SENCAR mice treated
with topical carcinogens (DMBA and TPA) were given lunasin (CL) or
vehicle (C). Other SENCAR mice were given vehicle instead of carcin-
ogen and were also treated with topical lunasin (L) or vehicle (N). 2H2O
label was administered during the 2 wk prior to euthanasia (see Fig 1a).
Fractional replacement (f) was determined as described in Fig 2a leg-
end. Data are mean  SD (n¼ 6 per group). Groups with different su-
perscript letters are significantly different (po0.05) by one-way ANOVA
with Bonferroni follow-up. (b) Female C57BL/6J mice were fed a 33%
calorically restricted diet for 4 wk (CR). Control mice were allowed AL
access to food (AL). 2H2O label was administered during the 2 wk prior
to euthanasia. Fractional replacement (f) was determined as described
in Fig 2a legend. Data are mean  SD (n¼4 per group). Asterisk de-
notes significant difference (p¼ 0.0004) by two-tailed Student’s t test.
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in vivo in both normal and carcinogen-treated SENCAR
mice, and that these anti-proliferative affects were detect-
able using the 2H2O labeling technique.
Caloric restriction (CR) markedly reduces epidermal cell
proliferation It has previously been shown that CR reduc-
es cell proliferation in various tissues, including the skin (Lok
et al, 1990). We studied the effects of CR (reduction in en-
ergy intake by 33%) for 4 wk in female C57BL/6 mice. After
4 wk of diet, calorically restricted mice had lost 18% of
body weight and weighed 28% less than control ad libitum
(AL) fed mice (14.4 g versus 20.0 g). Calorically restricted
and control mice were given 2H2O for 2 wk. CR significantly
reduced epidermal cell proliferation (by 45%) compared
with AL fed mice (Fig 3b, p¼0.0004), indicating that CR has
an inhibitory effect on keratinocyte proliferation.
Discussion
We describe and validate here a relatively simple method for
measuring the proliferation and die-away kinetics of kera-
tinocytes (epidermal cells) in rodents. This 2H2O labeling
technique has previously been shown to be highly repro-
ducible and sensitive to relatively small changes in cell
proliferation in other tissues (Neese et al, 2001, 2002). The
results presented here confirm that 2H2O labeling of DNA in
epidermal cells is also extremely sensitive to factors that
increase or decrease cell proliferation.
Previous methods of measuring cell proliferation include
static markers, such as Ki67 or PCNA staining (Mathews et
al, 1984; Schluter et al, 1993). These techniques do not re-
veal the actual rate at which cells are progressing through
the cell cycle and completing mitotic cell division, however.
Cell cycle markers are expressed in cells that are arrested in
G1/S, for example, so that an agent that reduces cell pro-
liferation by acting at the G1/S check-point will appear to
increase the cycling fraction, based on Ki67 staining (Hell-
erstein, 1999). Previously available dynamic measurements,
such as the incorporation of BrdU and 3HdT into cellular
DNA, also have limitations. These reagents are toxic and
mutagenic and, at high doses or after prolonged adminis-
tration, may impair cell division or kill susceptible cells
(Rocha et al, 1990; Asher et al, 1995). Moreover, incorpo-
ration of these pyrimidine deoxynucleoside precursors into
DNA occurs via nucleoside salvage pathways, the activity
of which is highly variable and influenced by a number
of factors, including the efficiency of nucleoside uptake
by different cells and the availability of extracellular
deoxyribonucleosides in the tissue (Cohen et al, 1983; Rei-
chard, 1988; Rocha et al, 1990; Hellerstein, 1999). These
variables introduce noise and systematic confounding ef-
fects into measurements of cell proliferation from pyrimidine
deoxyribonucleosides. Moreover, label decay results are
particularly difficult to interpret after BrdU and 3HdT label-
ing. Because these reagents tag cell lineages during cell
division, daughter cells remain ‘‘positive’’ for several gen-
erations (Cohen et al, 1983; Reichard, 1988), which com-
plicates interpretation of cell death during the label decay
phase (Hellerstein, 1999). In addition, it has been noted in
the past that some keratinocytes in S-phase do not incor-
porate labeled deoxyribonucleoside precursors into DNA
(Clausen et al, 1983). In contrast, the 2H2O endogenous
labeling method is safe, operates through the consti-
tutive and relatively invariant de novo nucleoside synthesis
pathway (Macallan et al, 1998; Hellerstein, 1999), and does
not depend on the deoxyribonucleoside salvage pathway,
thereby yielding highly reproducible results (Neese et al,
2001, 2002).
Our demonstration of a statistically significant 9%–16%
inhibitory effect of topical lunasin on keratinocyte prolifer-
ation in vivo with a relatively small number of animals (six
per group, Fig 3a) affirms the reproducibility and power of
this 2H2O labeling approach. The precision and ease of this
technique could facilitate future high-throughput evalua-
tions of agents intended to alter keratinocyte proliferation
(Gijbels et al, 2000; Pol et al, 2003; van de Kerkhof and
Vissers, 2003).
Lunasin decreased keratinocyte proliferation significantly
in both normal and carcinogen-treated SENCAR mice (Fig
3a). The SENCAR mouse with topical chemical carcinogen
treatment is a commonly used model of skin cancer (Chen
et al, 1995; Galvez et al, 2001). It is worth pointing out that
the 2H2O labeling method was able to detect a dramatic
increase in epidermal cell proliferation rate within 3 wk of
carcinogen treatment. Some traditional studies using the
SENCAR mouse model have relied on papilloma formation
as an indicator of carcinogenesis, a process that can take
up to 20 wk to develop (Galvez et al, 2001). In contrast, the
2H2O labeling method allows sensitive detection of changes
in epidermal cell proliferation within a much shorter time
period. This feature may prove useful for evaluating the ef-
ficacy of chemopreventive agents with anti-promotional/
anti-proliferative actions, such as lunasin (Galvez and de
Lumen, 1999; Galvez et al, 2001). In addition, the finding of
nearly 100% fractional replacement of epidermal cells in
carcinogen-treated epidermis suggests that normally qui-
escent cells are included among the targets of cutaneous
carcinogens, consistent with previous hypotheses (Morris
et al, 1988, 1997, 2000; Morris 2000).
We also demonstrated clearly that CR by 33% signifi-
cantly decreases epidermal cell proliferation in C57Bl/6J
mice, compared with AL fed control mice (45% reduction,
Fig 3b). This finding is consistent with a previous study in
which 25% CR regimen resulted in a 2-fold reduction in skin
cell proliferation in Swiss Webster mice, as measured by
3HdT labeling (Lok et al, 1990). CR by 30% has been re-
ported to decrease keratinocyte proliferation and papilloma
formation in NMRI mice treated with topical carcinogens
(Fischer and Lutz, 1998). Decreased rates of cell prolifera-
tion may in part mediate the reduction in carcinogenesis
observed in CR studies, through inhibition of promotion
(Hursting and Kari, 1999; Hursting et al, 2003). Measure-
ment of keratinocyte proliferation may prove useful as an
objective biomarker for investigating the anti-carcinogenic
mechanisms and mediators of CR (Hsieh and Hellerstein,
unpublished observations).
Finally, the 2H2O labeling method may provide important
clues as to the varieties of cells within the epidermis. The
finding that 10%–15% of epidermal cells did not divide after
6 wk of 2H2O labeling (Fig 2a) may be explained by the
non-proliferative dendritic cells, stem cells, and quiescent
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keratinocytes (Bickenbach, 1981; Tani et al, 2000; Potten
and Booth, 2002). The complementary finding from the label
die-away study that a small fraction of cells retained their
label 11 wk after discontinuing label (Fig 2c) provides ad-
ditional evidence for a slow turnover subpopulation, such as
stem cells, in the tissue. Previous results with 3HdT labeling
suggest that label-retaining cells comprise 1%–10% of the
basal layer in the epidermis (Bickenbach, 1981; Tani et al,
2000; Potten and Booth, 2002). Enrichments in keratinocyte
DNA (Fig 2c) fell from 5.6% to 0.3% (more precisely, from
7.0% at peak labeling [not shown] to 0.3%, as Fig 2c starts
1 wk after discontinuing 2H2O intake). Thus, 4%–5% of
labeled cells remained after 11 wk, which is also within the
range of the 10%–15% unlabeled cells at 6 wk of label
incorporation (Fig 2a). The numbers should not be over-
interpreted, however, because unlabeled cells after 6 wk of
2H2O administration (Fig 2a) are not necessarily all stem
cells (some could be Langerhans cells, etc.). In addition, it is
safe to say that not all stem cells will have divided during the
4–6 wk 2H2O intake period, as the lifespan of their daughter
cells is 6–12 wk (Fig 2c), in addition to the possibility that a
subset may be quiescent at any given time. Longer 2H2O
labeling periods might therefore result in more label-retain-
ing cells (Collins et al, 2003). It is also possible that some
recently divided cells could be non-stem (i.e., Langerhans
cells, etc.) or that there could also be degrees of ‘‘stem-
ness’’, wherein cells that do not divide during 2H2O intake
are more quiescent than the set of cells that divided over
4 wk. In any case, stable isotope labeling of keratinocytes
may be used as a tool to explore the ‘‘stemness’’ of cells
with different phenotypic markers within the epidermis, as
has been performed for colon epithelial cells (Kim et al,
2004), lymphocytes (Hellerstein et al, 2003), and bone mar-
row progenitor cells (Schwartz et al, 2000, 2003). Epidermal
stem cells are of interest, as they have been implicated
as the targets of carcinogenesis (Morris et al, 1988, 1997,
2000; Morris 2000).
In summary, we demonstrate here that keratinocyte pro-
liferation can be measured in vivo in rodents using the 2H2O
stable isotope labeling method in normal, hyper- and hypo-
proliferative conditions. Potential applications of the meth-
od include the pathophysiology of diseases such as pso-
riasis and carcinogenesis, the physiology of wound healing,
inquiries into basic skin biology and stem cell biology, rel-
atively high-throughput testing of anti-proliferative pharma-
ceutical agents, and other interventions such as CR that are
aimed at altering keratinocyte turnover.
Materials and Methods
Animal studies and administration of heavy water Eight-week-
old female C57BL/6J mice (The Jackson Laboratory, Bar Harbor,
Maine) were used. Mice received an intraperitoneal injection of
isotonic 100% 2H2O (Cambridge Isotope Laboratories, Cambridge,
Massachusetts) to bring their 2H2O content in body water up to
2.5%. For the label incorporation studies, mice were subsequently
maintained AL on drinking water that contained 4% 2H2O for 1, 2,
3, 4, 5, and 6 wk (n¼ 3 per time point). For the label die-away
studies, mice were maintained on 4% 2H2O for 4 wk, after which
time they were given unlabeled drinking water for 1, 2, 4, 8, and 12
wk (n¼ 3 per time point). The mice were then euthanized by cer-
vical dislocation and cardiac puncture under isoflurane anesthesia.
All procedures were approved by the University of California at
Berkeley Animal Use Committee.
Epidermal cell and bone marrow cell isolation The method for
epidermis isolation was adapted from previous techniques (Barlow
and Pye, 1980; Dlugosz et al, 1995; Inokuchi et al, 1995). Hair was
removed post-mortem from skin of the dorsum of the mice by
application of a hair remover lotion (Nair, Carter Products, New
York, New York). After the lotion was cleaned off using an alcohol
swab, a piece of skin from mouse dorsum was dissected (about
3 cm2). The skin was rinsed with phosphate buffer saline (Gibco,
Grand Island, New York), divided into three smaller pieces, im-
mersed in dispase II (Roche, Indianapolis, Indiana), and incubated
for 3.5 h at 371C on a shaker. The epidermis could then be peeled
cleanly from the dermis as thin white sheets. Femurs were also col-
lected, and bone marrow was flushed out using a needle and syringe
containing PBS, as previously described (Macallan et al, 1998).
Measurement of isotopic enrichments DNA After isolation of
epidermal and bone marrow cells, genomic DNA was prepared as
described previously (Hellerstein et al, 1999; McCune et al, 2000).
In brief, DNA was enzymatically hydrolyzed to free deoxyribonuc-
leosides. Treatment with a cation resin (Bio-Rad Laboratories,
Hercules, California) releases the deoxyribose (dR) moiety, which is
then converted to the pentane-tetraacetate (PTA) derivative by so-
dium borohydride reduction (Sigma-Aldrich Corp., St Louis, Mis-
souri) (Neese et al, 2001). PTA was analyzed by GC/MS, using a
model 5973 mass spectrometer and model 6890 gas chromato-
graph (Agilent, Inc., Palo Alto, California). Deuterium incorporation
was determined from the abundance of m/z 246 (Mþ 1 species)
relative to m/z 245 (Mþ 0 species) in samples, corrected for natural
abundance (baseline) values, to calculate excess Mþ 1 (EM1) abun-
dance, as previously described (Neese et al, 2001, 2002).
EM1 ðexcess molar fractionÞ
¼ ½Mþ1 abundancesample½Mþ0 þ Mþ1 abundancesample
 ½Mþ1 abundancebaseline½Mþ0 þ Mþ1 abundancebaseline
In the label incorporation studies, epidermal DNA enrichment was
compared with bone marrow DNA enrichment, the latter repre-
senting a nearly fully replaced tissue (Neese et al, 2002; Collins
et al, 2003), to calculate by comparison the fractional replacement
of epidermal cells.
Fraction of new cells ðfÞ ¼ dR enrichment ðEM1Þ; epidermal cells
dR enrichment ðEM1Þ; bone marrow cells
Based on previously performed label incorporation and die-away
studies, approximately 5% of bone marrow cells are quiescent
over a 1–4-wk study period (Neese et al, 2002; Collins et al, 2003).
These observations are also consistent with estimates of maximal
possible label incorporation of 2H2O into DNA in bone marrow
cells, based on combinatorial calculations of deuterium mass is-
otopomer abundances in deoxyribose (Neese et al, 2002; Heller-
stein and Neese, unpublished observations). The impact of in-
complete turnover of the reference tissue (bone marrow) on frac-
tional replacement is therefore modest but real (i.e., if the denom-
inator is 5% too low, the fractional replacement value calculated
will be roughly 5% too high). It should be noted that the shape of
the curve, and thus the replacement rate constant or half-life, is not
affected by the denominator used, however.
Body water Enrichment of 2H2O in body water from blood was
measured by a GC/MS technique that we have previously devel-
oped (Neese et al, 2001). Standard curves are generated by mixing
100% 2H2O with natural abundance H2O in known proportions.
Blood obtained from cardiac puncture was centrifuged to collect
serum, which was then reacted with calcium carbide chips (Sigma)
as described (Collins et al, 2003). Released acetylene gas was
then injected in a vial containing carbon tetrachloride (Sigma) and
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bromine (Sigma) for 2 h, generating tetrabromoethane. Cyclohex-
ene (Sigma) in carbon tetrachloride was then added to the sam-
ples, which were analyzed by GC/MS (selected ion monitoring of
m/z 265 and 266) (Neese et al, 2001). Enrichment of 2H2O was
calculated by comparison with standard curves of known mixtures
of 2H2O and natural abundance H2O.
SENCAR mice and topical carcinogen application (Fig
1b) Eight-week-old female SENCAR mice (National Cancer Insti-
tute, Bethesda, Maryland) were acclimated for a week before
starting on an AL soy-free diet of AIN-93M chow (Bio-Serv,
Frenchtown, New Jersey). At 10 wk of age, mice were randomly
divided into four treatment groups (n¼ 6 per group): carcinogen
(C), lunasin (L), carcinogen plus lunasin (CL), and neither (N). During
week 1, twice weekly lunasin (Research Genetics, Huntsville, Al-
abama) or vehicle treatments were begun. Lunasin (250 mg per wk)
in ethanol was applied on the shaven backs (about 3 cm2 area) of
groups L and CL, whereas groups C and N received ethanol ap-
plication (vehicle) alone. During week 2, twice weekly carcinogen
treatments were started, administered 4 h after lunasin or vehicle
treatments. DMBA (Sigma) in acetone (20 mg per 200 mL) was ap-
plied one time and TPA (Sigma) in acetone (1 mg per 200 mL) was
subsequently applied twice weekly for groups C and CL, whereas
groups L and N received acetone (vehicle) only. The lunasin, TPA
and vehicle treatments were continued until the end of the study (a
total of 4 wk). Two weeks after beginning the lunasin or vehicle
administration protocol, mice were given an intraperitoneal injec-
tion of 2H2O (2.5% body water) and maintained on 4%
2H2O in
drinking water, as described above, for the remaining 2 wk until
euthanization. Epidermal cells were isolated and DNA enrichments
were measured.
Caloric restriction regimen Eight-week-old female C57BL/6J
mice (The Jackson Laboratory) were divided into two diet groups
(n¼ 4 per group): 33% CR and AL fed. AL mice were fed a semi-
purified AIN-93M diet, whereas CR mice were fed an enriched AIN-
93M diet that contains 33% higher content of protein, minerals,
and vitamins per gram weight (Bio-Serv), at 67% of AL caloric
intake. CR mice were given their food allotment on Mondays,
Wednesdays, and Fridays, as described elsewhere (Pugh et al,
1999). The dietary regimen lasted for 4 wk. Two weeks into each
diet treatment, mice were given an intraperitoneal injection of
2H2O (2.5% body water) and maintained on 4%
2H2O in drinking
water for the remaining 2 wk until euthanization. Epidermal cells were
isolated and DNA enrichments were measured as described above.
Histology Sheets of epidermis were stained with hematoxylin and
eosin (Histo-Tec Laboratory, Hayward, California) to confirm that
epidermis was cleanly separated from dermis. The remaining der-
mis was also stained to confirm that all epidermis had been re-
moved. Hematoxylin and eosin staining confirmed that tissues
isolated consisted of epidermis and were not contaminated by
dermis. Because dermis contains slowly proliferating fibroblasts, it
is important to avoid dermal contamination, as this might alter
apparent keratinocyte kinetics. Conversely, histology also showed
that the dermis samples were free of epidermis. These results
confirm that epidermis can be cleanly isolated by this method
(Barlow and Pye, 1980; Dlugosz et al, 1995; Inokuchi et al, 1995).
Statistical analyses The two-tailed Student t test was used to
analyze CR data. Lunasin and/or carcinogen treatment groups
were compared by one-way ANOVA with Bonferroni follow-up at
an error rate of 5%.
This study was supported by the UC Discovery Grant, Biotechnology
Proposal BIO02-10294.
DOI: 10.1111/j.0022-202X.2004.23303.x
Manuscript received December 15, 2003; revised March 22, 2004; ac-
cepted for publication March 29, 2004
Address correspondence to: Marc K. Hellerstein, MD, PhD, Depart-
ment of Nutritional Sciences and Toxicology, 309 Morgan Hall, Uni-
versity of California, Berkeley, California 94720, USA. Email: march
@nature.berkeley.edu
References
Antelo F, Neese R, Hellerstein MK, et al: Measuring adipocyte proliferation in vivo
using 2H2O incorporation into DNA. FASEB J 14:A214, 2000
Asher E, Payne CM, Bernstein C, et al: Evaluation of cell death in EBV-trans-
formed lymphocytes using agarose gel electrophoresis, light microscopy
and electron microscopy. II. Induction of non-classic apoptosis (‘‘para-
apoptosis’’) by tritiated thymidine. Leuk Lymphoma 19:107–119, 1995
Barlow Y, Pye RJ: Keratinocyte culture. Methods Mol Biol 5:83–97, 1980
Bickenbach JR: Identification and behavior of label-retaining cells in oral mucosa
and skin. J Dent Res 60 (Spec no. 1):1611–1620, 1981
Chen LC, Tarone R, Huynh M, et al: High dietary retinoic acid inhibits tumor
promotion and malignant conversion in a two-stage skin carcinogenesis
protocol using 7,12-dimethylbenz[a]anthracene as the initiator and me-
zerein as the tumor promoter in female SENCAR mice. Cancer Lett
95:113–118, 1995
Christophers E, Schaumloffel E: On DNA synthesis time in the human epidermis.
Arch Klin Exp Dermatol 228:57–64, 1967
Chu A, Siler S, Cesar D, et al: An in vivo method for measuring vascular smooth
muscle cell (SMC) proliferation using [6,6-2H]glucose. FASEB J 13:A436,
1999
Clausen OP, Elgjo K, Kirkhus B, et al: DNA synthesis in mouse epidermis: S phase
cells that remain unlabeled after pulse labeling with DNA precursors
progress slowly through S. J Invest Dermatol 81:545–549, 1983
Cohen A, Barankiewicz J, Lederman HM, et al: Purine and pyrimidine metabolism
in human T lymphocytes. Regulation of deoxyribonucleotide metabolism.
J Biol Chem 258:12334–12340, 1983
Collins ML, Eng S, Hoh R, et al: Measurement of mitochondrial DNA synthesis
in vivo using a stable isotope-mass spectrometric technique. J Appl
Physiol 94:2203–2211, 2003
Dlugosz AA, Glick AB, Tennenbaum T, et al: Isolation and utilization of epidermal
keratinocytes for oncogene research. Methods Enzymol 254:3–20, 1995
Dover R: Cell kinetics of keratinocytes. In: Watt F (ed). The Keratinocyte Hand-
book. Cambridge: Cambridge University Press, 1993; p 203–234
Downes AM, Matoltsy AG, Sweeney TM, et al: Rate of turnover of the stratum
corneum in hairless mice. J Invest Dermatol 49:400–405, 1967
Epstein WL, Maibach HI: Cell renewal in human epidermis. Arch Dermatol
92:462–468, 1965
Fairley JA, Zivony D: Epidermal kinetics and regulation of cell proliferation. In:
Woodley DT (ed). The Biology of the Skin. New York: Parthenon Publish-
ing, 2001; p 201–220
Fischer WH, Lutz WK: Influence of diet restriction and tumor promoter dose on
cell proliferation, oxidative DNA damage and rate of papilloma appear-
ance in the mouse skin after initiation with DMBA and promotion with
TPA. Toxicol Lett 98:59–69, 1998
Galvez AF, Chen N, Macasieb J, et al: Chemopreventive property of a soybean
peptide (lunasin) that binds to deacetylated histones and inhibits ace-
tylation. Cancer Res 61:7473–7478, 2001
Galvez AF, de Lumen BO: A soybean cDNA encoding a chromatin-binding pep-
tide inhibits mitosis of mammalian cells. Nat Biotechnol 17:495–500,
1999
Gijbels MJ, Elliott GR, Hogenesch H, et al: Therapeutic interventions in mice with
chronic proliferative dermatitis (cpdm/cpdm). Exp Dermatol 9:351–358,
2000
Haake A, Scott GA, Holbrook KA, et al: Structure and function of the skin: Over-
view of the epidermis and dermis. In: Woodley DT (ed). The Biology of the
Skin. New York: Parthenon Publishing, 2001; p 19–45
Halprin KM: Epidermal ‘‘turnover time’’––a re-examination. Br J Dermatol 86:
14–19, 1972
Hellerstein M, Hanley MB, Cesar D, et al: Directly measured kinetics of circulating
T lymphocytes in normal and HIV-1-infected humans. Nat Med 5:83–89,
1999
Hellerstein MK: Measurement of T-cell kinetics: Recent methodologic advances.
Immunol Today 20:438–441, 1999
Hellerstein MK, Hoh RA, Hanley MB, et al: Subpopulations of long-lived and
short-lived T cells in advanced HIV-1 infection. J Clin Invest 112:956–966,
2003
Hursting SD, Kari FW: The anti-carcinogenic effects of dietary restriction: Mech-
anisms and future directions. Mutat Res 443:235–249, 1999
Hursting SD, Lavigne JA, Berrigan D, et al: Calorie restriction, aging, and cancer
prevention: Mechanisms of action and applicability to humans. Annu Rev
Med 54:131–152, 2003
DYNAMICS OF KERATINOCYTES IN VIVO USING 2H2O LABELING 535123 : 3 SEPTEMBER 2004
Inokuchi S, Shimamura K, Tohya H, et al: Effects of fibroblasts of different origin
on long term maintenance of xenotransplanted human epidermal
keratinocytes in immunodeficient mice. Cell Tissue Res 281:223–229,
1995
Jensen JE, Esterly NB: The ichthyosis mouse: Histologic, histochemical, ultra-
structural, and autoradiographic studies of interfollicular epidermis. J In-
vest Dermatol 68:23–31, 1977
Kim SJ, Cheung S, Hellerstein MK: Isolation of nuclei from label-retaining cells
and measurement of their turnover rates in rat colon. Physiology 286:
1464–1473, 2004
Kim J, Neese R, Hellerstein MK, et al: A new method to measure proliferation
rates of colon epithelial cells. FASEB J 14:A718, 2000
Lok E, Scott FW, Mongeau R, et al: Calorie restriction and cellular proliferation in
various tissues of the female Swiss Webster mouse. Cancer Lett 51:67–73,
1990
Macallan DC, Fullerton CA, Neese RA, et al: Measurement of cell proliferation by
labeling of DNA with stable isotope-labeled glucose: Studies in vitro, in
animals, and in humans. Proc Natl Acad Sci USA 95:708–713, 1998
Mathews MB, Bernstein RM, Franza Jr. BR, et al: Identity of the proliferating cell
nuclear antigen and cyclin. Nature 309:374–376, 1984
McCune JM, Hanley MB, Cesar D, et al: Factors influencing T-cell turnover in HIV-
1-seropositive patients. J Clin Invest 105:R1–R8, 2000
Misell L, Thompson J, Antelo F, et al: A new in vivo stable isotope method using
2H2O for measuring mammary epithelial cell proliferation. FASEB J 14:
A786, 2000
Mohri H, Tung K, Ramratnam B, et al: Rapid turnover of T lymphocytes in HIV-1
infection and its reduction by HAART: A kinetic study using deuterated
glucose. VIIth Conference on Retroviruses and Opportunistic Infections.
2000
Morris RJ: Keratinocyte stem cells: Targets for cutaneous carcinogens. J Clin
Invest 106:3–8, 2000
Morris RJ, Coulter K, Tryson K, et al: Evidence that cutaneous carcinogen-in-
itiated epithelial cells from mice are quiescent rather than actively cycling.
Cancer Res 57:3436–3443, 1997
Morris RJ, Tacker KC, Fischer SM, et al: Quantitation of primary in vitro
clonogenic keratinocytes from normal adult murine epidermis, following
initiation, and during promotion of epidermal tumors. Cancer Res
48:6285–6290, 1988
Morris RJ, Tryson KA, Wu KQ, et al: Evidence that the epidermal targets of
carcinogen action are found in the interfollicular epidermis of in-
fundibulum as well as in the hair follicles. Cancer Res 60:226–229, 2000
Neese RA, Misell LM, Turner S, et al: Measurement in vivo of proliferation rates of
slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA.
Proc Natl Acad Sci USA 99:15345–15350, 2002
Neese RA, Siler SQ, Cesar D, et al: Advances in the stable isotope-mass spec-
trometric measurement of DNA synthesis and cell proliferation. Anal
Biochem 298:189–195, 2001
Plewig G, Braun-Falco O: Kinetics of epidermis and adnexa following vitamin A
acid in the human. Acta Derm Venereol Suppl (Stockh) 74:87–98, 1975
Pol A, Bergers M, Schalkwijk J, et al: Comparison of antiproliferative effects of
experimental and established antipsoriatic drugs on human keratin-
ocytes, using a simple 96-well-plate assay. In Vitro Cell Dev Biol Anim
39:36–42, 2003
Potten CS: Epidermal transit times. Br J Dermatol 93:649–658, 1975
Potten CS, Booth C: Keratinocyte stem cells: A commentary. J Invest Dermatol
119:888–999, 2002
Proksch E, Feingold KR, Man MQ, et al: Barrier function regulates epidermal DNA
synthesis. J Clin Invest 87:1668–1673, 1991
Pugh TD, Klopp RG, Weindruch R, et al: Controlling caloric consumption: Proto-
cols for rodents and rhesus monkeys. Neurobiol Aging 20:157–165, 1999
Reichard P: Interactions between deoxyribonucleotide and DNA synthesis. Annu
Rev Biochem 57:349–374, 1988
Rocha B, Penit C, Baron C, et al: Accumulation of bromodeoxyuridine-labeled
cells in central and peripheral lymphoid organs: Minimal estimates of
production and turnover rates of mature lymphocytes. Eur J Immunol 20:
1697–1708, 1990
Schluter C, Duchrow M, Wohlenberg C, et al: The cell proliferation-associated
antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with
numerous repeated elements, representing a new kind of cell cycle-
maintaining proteins. J Cell Biol 123:513–522, 1993
Schwartz G, Vance B, Fukazawa M, et al: Measurement of in vivo proliferation
kinetics of human marrow CD34þ cells by quantitating [2H]glucose in-
corporation into DNA of S-phase cells. Am Soc Hematol, 662a, 2000
Schwartz GN, Vance BA, Levine BM, et al: Proliferation kinetics of subpopulat-
ions of human marrow cells determined by quantifying in vivo incorpo-
ration of [2H2]-glucose into DNA of S-phase cells. Blood 102:2068–2073,
2003
Strawford A, Antelo F, Christiansen M, et al: Adipose tissue triglyceride turnover,
de novo lipogenesis, and cell proliferation in humans measured with
2H2O. Am J Physiol Endocrinol Metab 286:E577–E588, 2004
Tani H, Morris RJ, Kaur P, et al: Enrichment for murine keratinocyte stem cells based
on cell surface phenotype. Proc Natl Acad Sci USA 97:10960–10965, 2000
van de Kerkhof PC, Vissers WH: The topical treatment of psoriasis. Skin Pharma-
col Appl Skin Physiol 16:69–83, 2003
Weinstein GD, McCullough JL, Ross PA: Cell kinetic basis for pathophysiology of
psoriasis. J Invest Dermatol 85:579–583, 1985
Weinstein GD, Van Scott EJ: Autoradiographic analysis of turnover times of nor-
mal and psoriatic epidermis. J Invest Dermatol 45:257–262, 1965
536 HSIEH ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
